AR037594A1 - Metodos para tratar infecciones bacterianas en perros y gatos - Google Patents
Metodos para tratar infecciones bacterianas en perros y gatosInfo
- Publication number
- AR037594A1 AR037594A1 ARP020104593A ARP020104593A AR037594A1 AR 037594 A1 AR037594 A1 AR 037594A1 AR P020104593 A ARP020104593 A AR P020104593A AR P020104593 A ARP020104593 A AR P020104593A AR 037594 A1 AR037594 A1 AR 037594A1
- Authority
- AR
- Argentina
- Prior art keywords
- cats
- bacterial infections
- dogs
- methods
- treat bacterial
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cephalosporin Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0130694.3A GB0130694D0 (en) | 2001-12-21 | 2001-12-21 | Treatment |
US35996102P | 2002-02-27 | 2002-02-27 | |
US39893302P | 2002-07-26 | 2002-07-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR037594A1 true AR037594A1 (es) | 2004-11-17 |
Family
ID=27256361
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP020104593A AR037594A1 (es) | 2001-12-21 | 2002-11-28 | Metodos para tratar infecciones bacterianas en perros y gatos |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP1455900A1 (zh) |
JP (1) | JP2005524611A (zh) |
CN (1) | CN1606463A (zh) |
AR (1) | AR037594A1 (zh) |
AU (1) | AU2002348985A1 (zh) |
BR (1) | BR0215070A (zh) |
CA (1) | CA2470995A1 (zh) |
IL (1) | IL162103A0 (zh) |
NO (1) | NO20043008L (zh) |
PL (1) | PL370624A1 (zh) |
TW (1) | TW200301126A (zh) |
WO (1) | WO2003053522A1 (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MXPA06012215A (es) * | 2004-04-22 | 2007-04-19 | Pfizer Prod Inc | Metodo de estabilizacion de la sal sodica cefovecina desordenada. |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2121745T3 (es) * | 1989-03-30 | 1998-12-16 | Pfizer | Cefalosporinas y sus homologos, procedimiento para su preparacion y composiciones farmaceuticas. |
GB9424847D0 (en) * | 1994-12-09 | 1995-02-08 | Smithkline Beecham Plc | Novel process |
GB2300856A (en) * | 1995-05-16 | 1996-11-20 | Pfizer Ltd | Beta-lactam preparation |
-
2002
- 2002-11-13 AU AU2002348985A patent/AU2002348985A1/en not_active Abandoned
- 2002-11-13 BR BR0215070-0A patent/BR0215070A/pt not_active IP Right Cessation
- 2002-11-13 PL PL02370624A patent/PL370624A1/xx not_active Application Discontinuation
- 2002-11-13 WO PCT/IB2002/004741 patent/WO2003053522A1/en not_active Application Discontinuation
- 2002-11-13 EP EP02781498A patent/EP1455900A1/en not_active Withdrawn
- 2002-11-13 JP JP2003554278A patent/JP2005524611A/ja active Pending
- 2002-11-13 CN CNA028256506A patent/CN1606463A/zh active Pending
- 2002-11-13 IL IL16210302A patent/IL162103A0/xx unknown
- 2002-11-13 CA CA002470995A patent/CA2470995A1/en not_active Abandoned
- 2002-11-19 TW TW091133726A patent/TW200301126A/zh unknown
- 2002-11-28 AR ARP020104593A patent/AR037594A1/es unknown
-
2004
- 2004-07-15 NO NO20043008A patent/NO20043008L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
NO20043008L (no) | 2004-09-01 |
EP1455900A1 (en) | 2004-09-15 |
CA2470995A1 (en) | 2003-07-03 |
BR0215070A (pt) | 2004-11-09 |
WO2003053522A1 (en) | 2003-07-03 |
CN1606463A (zh) | 2005-04-13 |
PL370624A1 (en) | 2005-05-30 |
AU2002348985A1 (en) | 2003-07-09 |
TW200301126A (en) | 2003-07-01 |
JP2005524611A (ja) | 2005-08-18 |
IL162103A0 (en) | 2005-11-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR037595A1 (es) | Metodos de tratamiento y formulaciones de cefalosporina | |
EA200501098A1 (ru) | Антибактериальные агенты | |
EA199901015A1 (ru) | 4"-замещенные производные 9-деоксо-9а-а3а-9а-гомоэритромицина а | |
BR0214736A (pt) | Composto e seus sais farmaceuticamente aceitáveis, composição farmacêutica e método de tratar seres humanos ou animais que sofrem de doenças ou condições | |
BR9915208A (pt) | Preparado farmacêutico de moxifloxacina | |
EA200100623A1 (ru) | Кетолидные антибиотики | |
EA200100416A1 (ru) | 13-членные азалиды и их применение в качестве антибиотических агентов | |
ATE496048T1 (de) | Phenylcarboxamidverbindungen zur schmerzbehandlung | |
BR9808290A (pt) | Composto, composição farmacêutica, processo de tratar infecções bacterianas em seres humanos e animais, uso de um composto, e, processo para sua preparação | |
DE60120752D1 (de) | Verwendung von cyclopropancyclus enthaltenden carbonsäureverbindungen als medikament | |
PT911331E (pt) | Compostos de dibenzoxazepina substituidos composicoes farmaceuticas e metodos de utilizacao | |
RU94008616A (ru) | 2-тиозамещенные карбапенемы, промежуточные соединения для получения, способы получения, фармацевтическая композиция, способ лечения бактериальных инфекций | |
DE69932939D1 (de) | Fulvinsäure und dessen verwendung zur behandlung von diversen krankheitszuständen | |
ATE268337T1 (de) | C11-carbamate von antibakteriellen makroliden | |
PT1132392E (pt) | Antibioticos cetolidos | |
NO923200D0 (no) | Piperidin-derivater | |
FI933681A (fi) | Antimikrobiellt medel | |
BR0015722A (pt) | Uso de derivados de pleuromutilina para tratamento transdérmico de doenças bacterianas | |
AR037594A1 (es) | Metodos para tratar infecciones bacterianas en perros y gatos | |
BR0006301A (pt) | Macrólidos antibacterianos e pró-cinéticos | |
ID22543A (id) | Senyawa karbapenem, penggunaan dan senyawa antaranya | |
BR9915639A (pt) | Uso de derivados de ácido fosfonofórmico para o tratamento de infecções | |
BR0308118A (pt) | Método para o tratamento de osteoartrite | |
BR0110932A (pt) | Alimento seco destinado alimentação dos cães e utilização do mesmo | |
EA200100444A1 (ru) | Производные гигромицина а в качестве антибактериальных агентов |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |